Objective: Accumulating evidence raises the hypothesis that dysregulation of intrinsic clock mechanisms are involved in the development of the metabolic syndrome, type 2 diabetes mellitus and cardiovascular disease. The aim of the present study was to investigate the relationship between three known common polymorphisms in the Clock gene and features of the metabolic syndrome in man. Methods: Genotype and haplotype analysis was carried out in a cohort of 537 individuals from 89 families characterized for inflammatory, atherothrombotic and metabolic risk associated with insulin resistance. Results: Heritability of the metabolic syndrome, defined according to International Diabetes Federation criteria, was 0.40. Haplotype analysis indicated three common haplotypes: CAT, TGT and CGC (rs4864548-rs3736544-rs1801260) with frequencies of 31, 33 and 28%, respectively. The CGC haplotype was less prevalent in subjects with the metabolic syndrome (P ¼ 0.0015) and was associated with lower waist circumference (P ¼ 0.007), lower hip circumference (P ¼ 0.023), lower body mass index (P ¼ 0.043) and lower leptin levels (P ¼ 0.028). The CAT haplotype was significantly associated with the presence of the metabolic syndrome (P ¼ 0.020). Conclusions: These findings suggest that the Clock gene CGC haplotype may be protective for the development of obesity and support the hypothesis that genetic variation in the Clock gene may play a role in the development of the metabolic syndrome, type 2 diabetes and cardiovascular disease.
Introduction
In recent years understanding of the importance of circadian rhythmicity and its role in normal physiological and pathological processes has increased tremendously. [1] [2] [3] [4] [5] Glucose, lipids, adiponectin, insulin, leptin, plasminogen activator inhibitor-1 (PAI-1), and blood pressure (BP) in humans are all known to exhibit circadian variation, 3 and it is of interest and concern that disturbing circadian rhythms in humans by shift work, or repeated sleep deprivation is associated with an increased prevalence of features of the metabolic syndrome [6] [7] [8] [9] [10] and an increased risk of cardiovascular disease.
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Circadian and seasonal rhythms in mammals, including man, are predominantly organized by light exposure regulating a central clock in the hypothalamic suprachiasmatic nucleus. 12, 13 This in turn appears to entrain clocks in peripheral cells, through neural or hormonal signals, to keep the organism functioning in time with itself and the environment. 12, 13 Central to the timing and accuracy of these rhythms is a complex system of positive and negative feedback loops based on transcriptional activation and repression of Clock genes and degradation of clock proteins. 12, 13 There are several core clock proteins (CLOCK, BMAL1, Per1, Per2, Per3, Cry1 and Cry2), which drive the feedback loops leading to the development of an oscillating system that regulates the cyclical phenotype in response to day length and the seasons. 12, 13 are associated with impaired glucose tolerance. 19 In the mouse adipocyte, Clock gene expression is attenuated in the presence of obesity with loss of the circadian rhythmicity of expression of adipocytokines and attenuated adiponectin levels. 16 These findings support the hypothesis that a functional relationship exists between the circadian clock and development of the metabolic syndrome. The aim of the present study was to investigate the relationship between three known common polymorphisms in the Clock gene and features of the metabolic syndrome in man. This was carried out by genotype and haplotype analysis in a cohort of 537 individuals from 89 families characterized for inflammatory, atherothrombotic and metabolic risk associated with insulin resistance.
Subjects, materials and methods

Subjects
Details of the subject recruitment and characteristics have been previously published 20, 21 and are shown in Tables 1 and   2 . In brief, potential subjects were selected at random from the Family Health Authority register in Leeds, and included in the study if healthy and if X4 first-, second-or thirddegree relatives were able to take part. 
Sampling methods
To minimize the influence of circadian rhythm on plasma measurements, subjects were studied between 0700 and 1100 after a 10 h overnight fast. Blood samples were drawn from an antecubital vein with a 19-gauge needle without venous stasis. Aliquots of plasma were snap-frozen in liquid nitrogen and stored at À40 1C until assay. Genomic DNA was extracted from 10 ml of whole blood using a Nucleon DNA extraction kit (Tepnel Life Sciences PLC, Manchester, UK).
Plasma measurements
Measures of insulin, glucose, homeostasis model of assessmentFinsulin resistance (HOMA-IR), PAI-1, cholesterol and triglycerides were assayed as previously described. 20 Adiponectin was assayed by an in-house enzyme-linked immunosorbant assay (ELISA) using antibodies from R&D systems (Oxon, UK). Leptin was assayed using a commercial ELISA from ADI (Autogen Bioclear, Wilts, UK).
Genotyping
Rs4864548, a C/T polymorphism in the Clock gene promoter, was genotyped by restriction fragment length polymorphism (RFLP) using Mbo II, which recognizes the T allele but not the C allele, to digest a 190 bp PCR product amplified with forward primer 5 0 -CTTTTCCAGTAGAAGCACTGAA-3 0 and a mismatch reverse primer designed to destroy a common Mbo II site two bases downstream of the polymorphic site 5 0 -AATCAAGTGACAGTGTAATGCAA-3 0 (mismatch base underlined). Rs3736544 (2121G/A), a synonymous coding region polymorphism (Asn588Asn), was genotyped by RFLP using Fok I, which recognizes the G allele but not the A allele, to digest a 0 . Rs1801260 (3111T/C), a polymorphism in the 3 0 -UTR, was genotyped by RFLP using Bsp1286I, which recognizes the C allele but not the T allele, to digest a 387 bp product amplified with forward primer 5 0 -TTGACATCAAGGGAG GAAGG-3 0 and reverse primer 5 0 -CCCTGACATGGCAGTG GTAT-3
0 . An evaluation of these three polymorphisms using Tagger (http://www.broad.mit.edu/mpg/tagger/) indicated that of
Sample size
Little of a formal nature is known about sample size requirements for studies of traits based on pedigrees, partly because pedigrees vary in their information content as a function of both their size and structure. However, we have previously shown that this study has sufficient power to detect minor contributions (B2%) of polymorphisms to variance in quantitative traits in the Leeds Family Study 23 and many analyses of this type to date have used sample sizes of around 500 or fewer individuals.
Statistical analysis SPSS v12 (SPSS Inc.) was used for data preparation and initial analysis of the data. Linkage disequilibrium between polymorphisms was analysed using Haploview. 24 The heritability of the metabolic syndrome and composite discrete traits were analysed using a liability threshold model in Southwest Foundation for Biomedical Research. PBAT v3.5 25 was used to determine the association of haplotype with the metabolic syndrome, composite discrete traits and other quantitative traits associated with the metabolic syndrome, using the population mean for the traits as the offset value. Three genetic models were tested additive, dominant and recessive. A P-value of 0.05 was taken as significant. Mendelian errors were indicated in two pedigrees and the two individuals with inconsistent genotyping data were excluded from analysis.
Results
The clinical characteristics of the subjects and the breakdown of their relationships are shown in Tables 1 and 2, respectively. Utilizing the IDF definition, 22 132 of the 537 family members had the metabolic syndrome. The heritability of the metabolic syndrome and its component discrete traits are shown in Table 3 . The heritability of the metabolic syndrome was 0.40 and that of the component traits ranged between 0.18 and 0.50.
The genotype distributions of the three Clock gene polymorphisms were in Hardy-Weinberg equilibrium. The T-allele frequency of rs4864548 was 0.32, A-allele frequency of rs3736544 was 0.35 and C-allele frequency of rs1801260 was 0.34. There were no significant associations between any of the polymorphisms and the metabolic syndrome or its subcomponents (data not shown).
The three polymorphisms were in significant linkage disequilibrium, with the rarer allele of each polymorphism occurring more frequently with the more common allele of the other. Haplotype analysis indicated three common haplotypes: CAT, TGT and CGC (rs4864548-rs3736544-rs1801260) with frequencies of 31, 33 and 28%, respectively. In recessive model analyses of the metabolic syndrome and its components, the CGC haplotype was less prevalent in those with the metabolic syndrome (P ¼ 0.0015) and in those with increased waist circumference (P ¼ 0.036), whereas the CAT haplotype was more prevalent in those with the metabolic syndrome (P ¼ 0.020). For analyses of quantitative traits, the CGC haplotype was associated with lower waist circumference (P ¼ 0.007), lower hip circumference (P ¼ 0.023), lower body mass index (BMI; P ¼ 0.043) and lower leptin levels than the other haplotypes (P ¼ 0.028). There were no significant associations between Clock haplotypes and lipids, insulin, glucose, PAI-1 or adiponectin (data not shown).
Discussion
This is the first study to report an association between Clock gene polymorphisms and the metabolic syndrome in man. It is also the first to report the heritability of the metabolic syndrome and its component traits in a White European population using the IDF criteria, which places waist circumference as a primary determinant of the definition. After adjusting for age and sex the heritability of the metabolic syndrome was 0.40 in our White European population. This is similar to a heritability of 0.38 recently reported in an Arab population also using the IDF definition 26 and a previous study using National Cholesterol Education Clock polymorphisms and obesity EM Scott et al
Program/Adult Treatment Panel III criteria showed the heritability of the metabolic syndrome to be 0.24 in a Caribbean-Hispanic population. 27 The present study further supports a role for genetic factors in the familial clustering of the metabolic syndrome and its component and related traits.
Haplotype analysis demonstrated that the Clock CGC haplotype was less prevalent in subjects with the metabolic syndrome and in those with increased waist circumference defined according to the IDF metabolic syndrome criteria. Furthermore the CGC haplotype was associated with decreased waist circumference, hip circumference, BMI and leptin levels, suggesting that this haplotype may be protective for the development of obesity. This is the only haplotype to include the C allele of rs1801260, suggesting that this polymorphism may be functional or in linkage disequilibrium with a functional polymorphism elsewhere in the Clock gene locus and warrants further investigation. In support of these findings a recent study has demonstrated an association of the C allele of rs1801260 with lifetime lower body weight in a group of subjects with eating disorders, 28 supporting a protective role for this allele and associated haplotype with obesity. The CAT haplotype showed an association with the presence of the metabolic syndrome. This is the only haplotype to include the A allele of the rs3736544 polymorphism. It was not however, associated with any of the component traits of the metabolic syndrome. Taken together, these findings support the evolving view that the circadian oscillator has an important role in the development of obesity and the metabolic syndrome, 1, 29, 30 which is largely based on animal studies: [17] [18] [19] the Clock mutant mouse has altered feeding patterns accompanied by the development of obesity, elevated triglycerides, glucose and leptin 18 and mutations in Clock and Bmal alter diurnal variation in triglycerides and glucose. 17 Although we did not perform any assessment of sleep patterns in our subjects, it is of interest that the rs1801260 polymorphism has previously been associated with sleep dysregulation in humans in many [31] [32] [33] [34] [35] [36] [37] [38] but not all studies. 39 These findings, together with the present results may provide genetic evidence to support epidemiological studies associating sleep disturbance with the development of diabetes and obesity. 9, 10 In addition, linkage studies in several populations have reported some indication of linkage with obesity, type 2 diabetes mellitus and insulin resistance in a region on chromosome 4q that encompasses the Clock gene. [40] [41] [42] [43] [44] [45] It has also recently been reported that the expression of several components of the molecular clock (Per2,Cry1, Bmal1) in adipose tissue are associated with features of the metabolic syndrome in man. 46 
Study limitations
When interpreting these findings it should be borne in mind that this is a small family study performed in largely healthy individuals. It will be important to confirm these findings in future studies with larger populations. A further limitation of the study is that only three polymorphisms were examined and they may not be functional. In the light of our findings it will be important to further establish the effects of rs1801260 on gene regulation.
Conclusions
It has been proposed that loss of circadian and seasonal rhythms of light exposure and food intake with disruption of clock synchronicity may be responsible for the development of obesity and the metabolic syndrome. 1, 29, 30 The finding that the Clock CGC haplotype is associated with decreased waist circumference and other measures of obesity and is less prevalent in those with the metabolic syndrome defined according to the IDF criteria, in which increased waist circumference is a requirement, support the Clock gene as a candidate gene for obesity. Understanding the mechanisms underpinning the relationship between the environment, our circadian rhythms and obesity in the development of type 2 diabetes and cardiovascular disease will provide important pathways for both prevention and management of these conditions.
